John M. Klopp
Chief Tech/Sci/R&D Officer at ACER THERAPEUTICS INC.
Profile
John M.
Klopp is currently the Chief Technical Officer at Acer Therapeutics, Inc. Prior to this, he worked as the Senior Director-Manufacturing Management at Ultragenyx Pharmaceutical, Inc. from 2013 to 2018.
Mr. Klopp received his undergraduate degree from The Pennsylvania State University and his graduate degree from the University of California, Berkeley.
John M. Klopp active positions
| Companies | Position | Start |
|---|---|---|
| ACER THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01/09/2019 |
Former positions of John M. Klopp
| Companies | Position | End |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/01/2018 |
Training of John M. Klopp
| The Pennsylvania State University | Undergraduate Degree |
| University of California, Berkeley | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| Private companies | 1 |
|---|---|
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
- Stock Market
- Insiders
- John M. Klopp